Search results
Edison International CEO J. Andrew Murphy sells $4.1m in stock By Investing.com
Investing.com· 2 days agoEdison International (NYSE:EIX) President and CEO J. Andrew Murphy has sold a total of $4.1 million...
Earnings call: SkyWater Technology reports record Q1 revenue, mixed outlook By Investing.com
Investing.com· 5 days agoSkyWater Technology (ticker: SKYT), a semiconductor manufacturer, reported a record revenue of $79.6...
Earnings call: Journey Medical Q1 2024 financials show growth and promise
Investing.com· 4 days agoJourney Medical Corp. (Ticker: JMED) reported a revenue increase of 7% to $13 million in the first...
Earnings call: CS Disco Holdings sees revenue growth in Q1, appoints new CEO
Investing.com· 4 days agoCS Disco (OTC: DSCSY ) Holdings (ticker: DISCO), a provider of legal technology solutions, has...
Earnings call: CS Disco Holdings sees revenue growth in Q1, appoints new CEO By Investing.com
Investing.com· 3 days agoCS Disco (OTC:DSCSY) Holdings (ticker: DISCO), a provider of legal technology solutions, has...
Earnings call: LifeStance Health outperforms in Q1; raises full-year guidance
Investing.com· 5 days agoLifeStance Health, a leading provider of outpatient mental health services, has reported a robust...
Artivion executive sells shares worth over $29k By Investing.com
Investing.com· 4 days agoArtivion, Inc.'s (NYSE:AORT) Senior Vice President and General Counsel, Jean F. Holloway, has sold a...
Earnings call: Augmedix posts 40% revenue surge, revises full-year outlook
Investing.com· 4 days agoAugmedix, Inc. (ticker: AUGX) has reported a notable 40% increase in revenue for the first quarter...
Viemed Healthcare director Sabrina Heltz buys $19.9k in company shares By Investing.com
Investing.com· 3 days ago(NASDAQ:VMD), acquired additional shares in the company, signaling a positive endorsement of the...
Earnings call: Xenon Pharmaceuticals reports on Q1 2024 progress By Investing.com
Investing.com· 7 days agoXenon (NASDAQ:XENE) Pharmaceuticals Incorporated (ticker: XENE), a clinical-stage biopharmaceutical...